306 related articles for article (PubMed ID: 25943786)
1. Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma.
Sawyer JR; Tian E; Heuck CJ; Johann DJ; Epstein J; Swanson CM; Lukacs JL; Binz RL; Johnson M; Sammartino G; Zangari M; Davies FE; van Rhee F; Morgan GJ; Barlogie B
Blood; 2015 Jun; 125(24):3756-9. PubMed ID: 25943786
[TBL] [Abstract][Full Text] [Related]
2. An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome.
Sawyer JR; Tian E; Walker BA; Wardell C; Lukacs JL; Sammartino G; Bailey C; Schinke CD; Thanendrarajan S; Davies FE; Morgan GJ; Barlogie B; Zangari M; van Rhee F
Blood Cancer J; 2019 Aug; 9(8):62. PubMed ID: 31399558
[TBL] [Abstract][Full Text] [Related]
3. Jumping translocations of 1q12 in multiple myeloma: a novel mechanism for deletion of 17p in cytogenetically defined high-risk disease.
Sawyer JR; Tian E; Heuck CJ; Epstein J; Johann DJ; Swanson CM; Lukacs JL; Johnson M; Binz R; Boast A; Sammartino G; Usmani S; Zangari M; Waheed S; van Rhee F; Barlogie B
Blood; 2014 Apr; 123(16):2504-12. PubMed ID: 24497533
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a novel mechanism for gene amplification in multiple myeloma: 1q12 pericentromeric heterochromatin mediates breakage-fusion-bridge cycles of a 1q12 approximately 23 amplicon.
Sawyer JR; Tian E; Thomas E; Koller M; Stangeby C; Sammartino G; Goosen L; Swanson C; Binz RL; Barlogie B; Shaughnessy J
Br J Haematol; 2009 Nov; 147(4):484-94. PubMed ID: 19744130
[TBL] [Abstract][Full Text] [Related]
5. Novel evidence of a role for chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma.
Le Baccon P; Leroux D; Dascalescu C; Duley S; Marais D; Esmenjaud E; Sotto JJ; Callanan M
Genes Chromosomes Cancer; 2001 Nov; 32(3):250-64. PubMed ID: 11579465
[TBL] [Abstract][Full Text] [Related]
6. Genomic instability in multiple myeloma: evidence for jumping segmental duplications of chromosome arm 1q.
Sawyer JR; Tricot G; Lukacs JL; Binz RL; Tian E; Barlogie B; Shaughnessy J
Genes Chromosomes Cancer; 2005 Jan; 42(1):95-106. PubMed ID: 15472896
[TBL] [Abstract][Full Text] [Related]
7. Molecular cytogenetic analysis of genomic instability at the 1q12-22 chromosomal site in B-cell non-Hodgkin lymphoma.
Itoyama T; Nanjungud G; Chen W; Dyomin VG; Teruya-Feldstein J; Jhanwar SC; Zelenetz AD; Chaganti RS
Genes Chromosomes Cancer; 2002 Dec; 35(4):318-28. PubMed ID: 12378526
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of genetic aberrations in human multiple myeloma cell lines and newly diagnosed MM by fluorescence in situ hybridization].
An G; Xie ZQ; Li CH; Li Q; Yi SH; Qiu LG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1505-10. PubMed ID: 21176360
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 1 abnormalities in multiple myeloma.
Marzin Y; Jamet D; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
Anticancer Res; 2006; 26(2A):953-9. PubMed ID: 16619492
[TBL] [Abstract][Full Text] [Related]
10. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma.
Alpar D; de Jong D; Holczer-Nagy Z; Kajtar B; Savola S; Jakso P; David M; Kosztolanyi S; Kereskai L; Pajor L; Szuhai K
Genes Chromosomes Cancer; 2013 Sep; 52(9):785-93. PubMed ID: 23720363
[TBL] [Abstract][Full Text] [Related]
11. Genomic aberrations in anaplastic multiple myeloma: high frequency of 1q21(CKS1B) amplifications.
Bahmanyar M; Qi X; Chang H
Leuk Res; 2013 Dec; 37(12):1726-8. PubMed ID: 24169086
[TBL] [Abstract][Full Text] [Related]
12. Differences in nuclear positioning of 1q12 pericentric heterochromatin in normal and tumor B lymphocytes with 1q rearrangements.
Barki-Celli L; Lefebvre C; Le Baccon P; Nadeau G; Bonnefoix T; Usson Y; Vourc'h C; Khochbin S; Leroux D; Callanan M
Genes Chromosomes Cancer; 2005 Aug; 43(4):339-49. PubMed ID: 15846776
[TBL] [Abstract][Full Text] [Related]
13. Different breakage-prone regions on chromosome 1 detected in t(11;14)-positive mantle cell lymphoma cell lines and multiple myeloma cell lines are associated with different tumor progression-related mechanisms.
Rudolph C; Liehr T; Steinemann D; Emura M; Daibata M; Matsuo Y; Emi N; Abe M; Lai R; Mrasek K; Claussen U; Schlegelberger B
Cytogenet Genome Res; 2006; 112(3-4):213-21. PubMed ID: 16484775
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and biological characteristics multiple myeloma with 1q21 amplification].
Zhong S; Li C; Yi S; Qiu L
Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(8):615-9. PubMed ID: 26932854
[TBL] [Abstract][Full Text] [Related]
15. 1q21 amplification with additional genetic abnormalities but not isolated 1q21 gain is a negative prognostic factor in newly diagnosed patients with multiple myeloma treated with thalidomide-based regimens.
Grzasko N; Hus M; Chocholska S; Pluta A; Hajek R; Dmoszynska A
Leuk Lymphoma; 2012 Dec; 53(12):2500-3. PubMed ID: 22497640
[No Abstract] [Full Text] [Related]
16. Prognostic power of abnormal cytogenetics for multiple myeloma: a multicenter study in China.
Lai YY; Huang XJ; Cai Z; Cao XS; Chen FP; Chen XQ; Chen BA; Fang MY; Feng JF; Fu WL; Guo HY; Hou M; Hou J; Hu Y; Hu XT; Hu XM; Huang LQ; Jin J; Li JY; Li J; Li W; Liang YM; Liu T; Liu QF; Liu YH; Mao P; Ouyang J; Qiu LG; Qiu L; Shao CK; Shi B; Song YP; Sun ZM; Wang QS; Wang C; Wang JM; Wang YS; Wang Z; Wu JB; Wu YX; Xia RX; Xue YQ; Yang BZ; Yang G; Yang ZL; Yu L; Yuan Z; Zhang S; Zhang Y; Zhao HG; Zhao L; Zhou DB; Zou SH; Zhu YF
Chin Med J (Engl); 2012 Aug; 125(15):2663-70. PubMed ID: 22931972
[TBL] [Abstract][Full Text] [Related]
17. [Cytogenetic study of multiple myeloma].
Zhang Y; Jiang B; Huang XJ; Shi Y; He Q; Dang H; Qiu JY; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):76-8. PubMed ID: 17490526
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 1q21 abnormalities in multiple myeloma.
Schmidt TM; Fonseca R; Usmani SZ
Blood Cancer J; 2021 Apr; 11(4):83. PubMed ID: 33927196
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma.
Inoue J; Otsuki T; Hirasawa A; Imoto I; Matsuo Y; Shimizu S; Taniwaki M; Inazawa J
Am J Pathol; 2004 Jul; 165(1):71-81. PubMed ID: 15215163
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.
Su XY; Wong N; Cao Q; Yu LZ; Niu C; Wickham N; Johnson PJ; Chen Z; Chen SJ
Cancer Genet Cytogenet; 1999 Jan; 108(1):6-12. PubMed ID: 9973917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
